Skip to main content
Veterinary Medicines

Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablet

Authorised
  • Amoxicillin trihydrate
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)

Product identification

Medicine name:
Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablet
Clavucill 200 mg + 50 mg 200 mg - 50 mg Comprimé
Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablette
Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablet
Active substance:
  • Amoxicillin trihydrate
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    229.55
    milligram(s)
    /
    1.00
    Tablet
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
    125.10
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 250
  • Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 100
  • Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 10

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V343156
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0024/002
Concerned member states:
  • Denmark
  • France
  • Germany
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
Generic of:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 4/01/2022
Download
Dutch (PDF)
Published on: 1/02/2022
French (PDF)
Published on: 1/02/2022

Labelling

English (PDF)
Published on: 4/01/2022
Download

Package Leaflet

English (PDF)
Published on: 4/01/2022
Download
Dutch (PDF)
Published on: 1/02/2022
French (PDF)
Published on: 23/03/2022
German (PDF)
Published on: 2/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."